Automate Your Wheel Strategy on HLVX
With Tiblio's Option Bot, you can configure your own wheel strategy including HLVX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HLVX
- Rev/Share 0.0
- Book/Share 2.9496
- PB 0.6984
- Debt/Equity 0.1593
- CurrentRatio 26.3935
- ROIC -0.4473
- MktCap 103290592.0
- FreeCF/Share -1.224
- PFCF -1.6839
- PE -1.452
- Debt/Assets 0.1346
- DivYield 0
- ROE -0.4461
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders
Published: August 04, 2025 by: PRNewsWire
Sentiment: Neutral
MILWAUKEE , Aug. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with XOMA Royalty Corporation. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
Read More
HilleVax (HLVX) Upgraded to Strong Buy: What Does It Mean for the Stock?
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
HilleVax (HLVX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
About HilleVax, Inc. (HLVX)
- IPO Date 2022-04-29
- Website https://www.hillevax.com
- Industry Biotechnology
- CEO Robert M. Hershberg
- Employees 14